THERAPEUTICS
Ginkgo biloba does not reduce incidence of dementia in elderly people
| The first 150 words of the full text of this article appear below. |
Does Ginkgo biloba reduce the incidence of dementia and Alzheimers disease (AD) in elderly people with normal cognition or mild cognitive impairment?
3069 community volunteers aged 75 years or older (mean age 79.1 years, 46% women). Participants with mild cognitive impairment (MCI, n = 482) were included (see online notes for list of main exclusion criteria).
Five US academic medical centres; 2000–2008.
G biloba (120 mg extract EGb 761 twice daily) or placebo.
All cause dementia and AD (DSM-IV), as determined by the consensus of an expert panel reviewing clinical assessments and scores on the Modified Mini-Mental State Examination, the Clinical Dementia Rating scale, the Alzheimer Disease Assessment Scale and the GEM Study Neuropsychological Battery (administered once scores in at least two of the other tests had declined by a specified number of points or the participant had been diagnosed with dementia or given anti-dementia drugs by their personal physician).
Dr Willmar Schwabe GmbH & Co. KG Pharmaceuticals, Karlsruhe, Germany
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
